Clinical studies with atenolol in hypertension. 1977

J C Petrie, and T A Jeffers, and D B Galloway, and J Webster

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001262 Atenolol A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect. ICI-66082,Tenormin,Tenormine,ICI 66082,ICI66082

Related Publications

J C Petrie, and T A Jeffers, and D B Galloway, and J Webster
December 1976, Clinical science and molecular medicine. Supplement,
J C Petrie, and T A Jeffers, and D B Galloway, and J Webster
January 1984, JPMA. The Journal of the Pakistan Medical Association,
J C Petrie, and T A Jeffers, and D B Galloway, and J Webster
May 1981, La Clinica terapeutica,
J C Petrie, and T A Jeffers, and D B Galloway, and J Webster
October 1984, The Journal of the Association of Physicians of India,
J C Petrie, and T A Jeffers, and D B Galloway, and J Webster
March 1981, Harefuah,
J C Petrie, and T A Jeffers, and D B Galloway, and J Webster
January 1982, Vutreshni bolesti,
J C Petrie, and T A Jeffers, and D B Galloway, and J Webster
June 1983, La Clinica terapeutica,
J C Petrie, and T A Jeffers, and D B Galloway, and J Webster
May 1976, Clinical pharmacology and therapeutics,
J C Petrie, and T A Jeffers, and D B Galloway, and J Webster
December 1976, Clinical science and molecular medicine. Supplement,
J C Petrie, and T A Jeffers, and D B Galloway, and J Webster
October 1975, British medical journal,
Copied contents to your clipboard!